Used in pharmaceutical research as an intermediate in the synthesis of bioactive compounds targeting neurological pathways. Shows potential in the development of agents affecting neurotransmitter regulation due to its structural similarity to known neuroactive scaffolds. Also employed in studies exploring treatments for central nervous system disorders, including depression and cognitive impairments. Its derivatives are investigated for receptor binding properties, particularly related to monoamine systems. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies.